The aim of the research is:

• To offer an efficient and affordable hybrid anticancer drug with the local resources, which is anticipated to be not only a new efficient anticancer agent but also antifungal and anti-inflammatory as well as anti-viral.
• To re-preparing the novel anticancer drug that is discovered and published by the research group members of this proposal and then characterize to define the physiochemical properties as a  reference for the later hybrid compound.
• To build the stimulated pulse sequence reactor for the drug preparation.
• To combine the gold nanoparticles with the novel anticancer by sing the simulated pulse sequence technique in order to reach the physiochemical bonding of the nanoparticles with the functional group of the anticancer drug.
• To characterize the hybrid compound using the physical techniques such as FTIR and UV-VIS and Nuclear magnetic resonance (NMR) spectroscopy.
• To investigate the biological activity of the hybrid compound such as activity and toxicity.
• Working toward patenting and publishing the work.

Outcomes:

NA